Evidence map›Paper›PMID 28100935›Full record

ArticleMediators of inflammation2016

Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-

Xianguo Ren, Yun Bo, Junting Fan, Maosheng Chen, Daliang Xu, Yang Dong, Haowei He, Xianzhi Ren, Rong Qu, Yulian Jin and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediators of inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Antioxidant therapy against TGF-β/SMAD pathway involved in organ fibrosis.Journal of cellular and molecular medicine · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Xianguo RenNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China; Department of Pediatrics, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Yun BoDepartment of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Junting FanSchool of Pharmacy, Nanjing Medical University, Nanjing, China.
Maosheng ChenDepartment of Nephrology, Zhejiang Provincial People's Hospital, Hangzhou, China.
Daliang XuDepartment of Nephrology, Anhui Provincial Children's Hospital, Hefei, China; Nanjing University of Traditional Chinese Medicine, Nanjing, China.
Yang DongDepartment of Nephrology, Anhui Provincial Children's Hospital, Hefei, China; Nanjing University of Traditional Chinese Medicine, Nanjing, China.
Haowei HeDepartment of Urology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Xianzhi RenNanjing University of Traditional Chinese Medicine, Nanjing, China.
Rong QuDepartment of Nephrology, Anhui Provincial Children's Hospital, Hefei, China; Nanjing University of Traditional Chinese Medicine, Nanjing, China.
Yulian JinDepartment of Nephrology, Anhui Provincial Children's Hospital, Hefei, China; Nanjing University of Traditional Chinese Medicine, Nanjing, China.
Weihong ZhaoDepartment of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID 0000-0001-7809-6020
Changliang XuNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China; Nanjing University of Traditional Chinese Medicine, Nanjing, China.ORCID 0000-0001-6972-8460
Anhui Provincial Children's Hospital · CNNanjing General Hospital of Nanjing Military Command · CNJiangsu Province Hospital · CNNanjing Medical University · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the effect of Dalbergioidin (DAL), a well-known natural product extracted from

Indexed as

ActinsAnimalsAntibiotics, AntineoplasticCadherinsChromonesCollagen Type IIIDoxorubicinFibronectinsFibrosisGlutathioneKidneyKidney DiseasesMiceMuscle, SmoothNeuroprotective AgentsOxidation-ReductionActinsAntibiotics, AntineoplasticCadherinsChromonesCollagen Type IIIdalbergioidinDoxorubicinFibronectinsGlutathioneNeuroprotective AgentsPlant ExtractsSmad3 ProteinSmad3 protein, mouseSmad7 ProteinSmad7 protein, mouseTransforming Growth Factor beta

Identifiers

PMID28100935
PMCPMC5214096
OpenAlexW2567625445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.